The Globe and Mail reports in its Saturday, July 20, edition that it is harder these days for Canadian pot producers to raise capital. The Globe's Mark Rendell writes that on Friday, cannabis grower Flowr cancelled a $125-million public offering, citing in a news release "prevailing market conditions which were not conducive to the completion of the offering on terms that would be in the best interest of Flowr's current shareholders." The cancellation of Flowr's deal comes two weeks after the revelation of an industry-shaking breach of Health Canada rules by Canntrust. The Flowr offering was supposed to be underwritten by Credit Suisse Group, Barclays and BMO Nesbitt Burns. In May, Credit Suisse was part of the syndicate of banks that underwrote a $195.5-million (U.S.) financing by Canntrust, less than two months before Health Canada began its investigation. "In the case of Canntrust, the financing that they did right before the entire episode had substantial, highly credible syndicate partners, and those partners now have egg on their face. That is super negative for the entire sector and will have ripple effects that will play out over months and years," said Tantalus Labs boss Dan Sutton.